Eligen B12™
Eligen B12™ is a once-daily oral non-prescription medical food, which normalises B12 levels without injection.
Lynparza lowers death risk in Phase III prostate cancer trial
AstraZeneca and MSD partnered in July 2017 to jointly develop and commercialise Lynparza for various cancers. Credit: © AstraZeneca.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
MIT Optimal Sourcing Solutions
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator...
About
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator drugs, specialised in European Union (EU) open market solutions for clinical trials.
FollowMake an Enquiry
-
Emisphere Technologies
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced...
About
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced oral formulations for pharmaceutical developers.
FollowMake an Enquiry
-
VaLea Clinical Trials
VaLea Clinical Trials specialises in providing convenient patient-centric services for...
About
VaLea Clinical Trials specialises in providing convenient patient-centric services for clinical trials in the home or alternate-site settings, based in Vienna, Austria.
FollowMake an Enquiry